Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
(Reuters) - Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares of Cronos Group, Tilray Brands and Canopy Growth rose between...
10h ago
Biden administration takes step to make marijuana use a less serious crime
(Reuters) - The U.S. Department of Justice on Tuesday moved to make marijuana use a less serious crime, a source familiar with the matter said. If finalized, the policy change could potentially be the biggest shift in federal cannabis policy in 40 ...
10h ago
Breast cancer screening should begin at age 40, U.S. panel says
By Amina Niasse NEW YORK (Reuters) - Women at average risk for breast cancer should get screening mammograms every other year starting at age 40, the U.S. Preventive Services Task Force (USPSTF) said on Tuesday, cementing insurance coverage for the...
13h ago
Incyte misses quarterly profit on weak sales of lead drug
(Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition fr...
15h ago
GE HealthCare misses quarterly revenue estimates on weakness in China market
(Reuters) - GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell. The ...
16h ago
Ecolab to sell global surgical unit for $950 million, lifts 2024 profit forecast
(Reuters) - Water solutions company Ecolab said on Tuesday it would sell its global surgical solutions business to private medical supplier Medline for $950 million in cash and raised its full-year profit forecast. The unit made more than $400 mill...
16h ago
Walmart to close 51 US health centers
(Reuters) - Walmart said on Tuesday it plans to close 51 health centers across five states in the U.S., as well as shut virtual care centers, as the company looks to optimize its business operations in the country. "This is a difficult decision, an...
18h ago
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose 3.6% premarket. Sky-rocketing demand for Mounjaro and Z...
18h ago
Risk of bird flu spreading to cows outside US, says WHO
GENEVA (Reuters) - A World Health Organization official said on Tuesday there was a risk of H5N1 bird flu virus spreading to cows in other countries beyond the United States through migratory birds. "With the virus carried around the world by migra...
19h ago
Japan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansion
By Rocky Swift TOKYO (Reuters) - Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets. WHY IT'S IMPORTANT With this deal, Ono Pharma joins J...
20h ago
Sandoz reaches agreement with Amgen over patent dispute
ZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars. The agreement clears the way for th...
22h ago
Australian regulator weighs India spice mix issue for possible recall
By Rishika Sadam and Aditya Kalra HYDERABAD/NEW DELHI (Reuters) - Australia's food safety agency said on Tuesday it was weighing accusations of contamination about some spice mixes sold by Indian companies MDH and Everest to decide if a food recal...
Apr 30, 2024
J&J, Bristol Myers lose challenges to US drug price negotiation program
By Brendan Pierson (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medi...
Apr 29, 2024
UnitedHealth hackers took advantage of Citrix vulnerabilty to break in, CEO says
By Zeba Siddiqui SAN FRANCISCO (Reuters) - Hackers broke into UnitedHealth's tech unit on Feb. 12 by exploiting a security vulnerability in software from private IT company Citrix that allows employees remote access to their desktop computers, the ...
Apr 29, 2024
US FDA grants full approval for Pfizer's cervical cancer drug
(Reuters) - The U.S. Food and Drug Administration granted traditional approval for Pfizer's drug for cervical cancer patients with disease progression on or after chemotherapy, the agency said on Monday. (Reporting by Pratik Jain in Bengaluru; Edi...
Apr 29, 2024
State health plans must cover gender-affirming surgery, US appeals court rules
By Brendan Pierson (Reuters) - Health insurance plans run by U.S. states must cover gender-affirming surgeries for transgender people, a U.S. appeals court ruled on Monday. The 8-6 opinion from the Richmond, Virginia-based 4th U.S. Circuit Court of...
Apr 29, 2024
USDA to test ground beef in US states with outbreaks of bird flu in dairy cows
By Tom Polansek CHICAGO (Reuters) - The U.S. Department of Agriculture said on Monday it is collecting samples of ground beef in states with outbreaks of bird flu in dairy cows for testing but remains confident the meat supply is safe. The USDA wil...
Apr 29, 2024
One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
(Reuters) - The U.S. Food and Drug Administration website showed on Monday one dose of Novo Nordisk's weight-loss drug Wegovy is available after being in short supply, while three other doses remained in limited availability due to increased demand...
Apr 29, 2024
Annovis' Alzheimer's treatment helps improve cognition in trial
(Reuters) -Annovis Bio said on Monday its Alzheimer's treatment showed significantly higher improvement in cognition in patients during a mid-stage trial. The company's drug buntanetap works by decreasing the production of amyloid beta protein, believ...
Apr 29, 2024
US FDA publishes final rule for laboratory developed tests
(Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting ...
Apr 29, 2024
India's Manipal Hospitals acquires majority stake in Medica Synergie
BENGALURU (Reuters) - India's Manipal Hospitals has agreed to acquire 87% stake in Medica Synergie and will integrate Medica Synergie into its portfolio and rebrand it, Manipal said on Monday. (Reporting by Ashna Teresa Britto in Bengaluru; Editin...
Apr 29, 2024
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
By Christy Santhosh (Reuters) -X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in patients 12 years of age and older, sending its shares up 16% before the bell. X4's mavorixafor, ...
Apr 29, 2024
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion
(Reuters) - Deciphera Pharmaceuticals said on Monday Japan's Ono Pharmaceutical Co will acquire the cancer drug developer for $2.4 billion in cash. Ono Pharma has offered $25.60 per share, a premium of 74.7% to the U.S. company's last closing price...
Apr 29, 2024
Morphosys says Novartis takeover progressing as planned for H1 2024
BERLIN (Reuters) - Morphosys said its takeover by Novartis was still expected to be closed in the first half of this year, in a statement responding to a possible safety risk reported by specialist news website STAT News that knocked the company's ...
Apr 29, 2024
Analysis-Philip Morris faces key test with US heated tobacco push
By Emma Rumney LONDON (Reuters) - Philip Morris International's goals for heated tobacco in the United States are reachable, analysts and investors say, even though rivals see limited potential in a market where vaping dominates. The world's bigges...
Apr 29, 2024